tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market
BDRX
Biodexa Pharmaceuticals
RESEARCH TOOLSreports

Biodexa Pharmaceuticals (BDRX) Income Statement

538 Followers

Biodexa Pharmaceuticals Income Statement

Last quarter (Q4 2025), Biodexa Pharmaceuticals's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q4, Biodexa Pharmaceuticals's net income was £-2.56M. See Biodexa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 0.00£ 0.00£ 381.00K£ 699.00K£ 578.00K
Gross Profit
£ -184.86K£ -5.44M£ -3.69M£ -4.41M£ -4.08M
Operating Expenses
£ 8.08M£ 3.76M£ 4.33M£ 4.52M£ 2.92M
Depreciation and Amortization
£ 184.86K£ 117.00K£ 283.00K£ 174.00K£ 403.00K
EBITDA
£ -8.08M£ -9.08M£ -7.16M£ -8.26M£ -5.66M
Operating Income
£ -8.27M£ -9.20M£ -8.01M£ -8.93M£ -7.00M
Other Income/Expenses
£ 1.92M£ 3.22M£ 529.00K£ 444.00K£ 892.00K
Pretax Income
£ -6.35M£ -5.98M£ -7.49M£ -8.49M£ -6.11M
Net Income
£ -6.24M£ -5.73M£ -7.08M£ -7.66M£ -5.46M
Per Share Metrics
Basic EPS
£ -60.00£ -1.16M£ -229.00K£ -4.94M£ -3.52M
Diluted EPS
£ -60.00£ -1.16M£ -229.00K£ -4.94M£ -3.52M
Weighted Average Shares Outstanding
 54.86K 61.95K 30.00 1.00 1.00
Weighted Average Shares Outstanding (Diluted)
 54.86K 61.95K 30.00 1.00 1.00
Currency in GBP

Biodexa Pharmaceuticals Earnings and Revenue History